Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
At its top dose of 15 mg, tirzepatide outperforms semaglutide (with a top dose of 2.4 mg)
Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
[41], GLP-1 receptor agonists represent a promising adjunct to BS in pediatric populations, with Semaglutide demonstrating superior efficacy in recent trials
Additionally, both Zhao et al
Quick Facts HQ: Indianapolis, Indiana, USA FY2024 Revenue: USD 45.0B FY2024 (+32% YoY)
